Astria Therapeutics Inc
(ATXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 202,301 | 20,525 | 45,972 | 29,826 | 46,687 |
| Marketable Securities | 11,027 | 205,912 | 70,599 | 72,652 | 66,129 |
| TOTAL | $215,445 | $227,690 | $118,485 | $103,821 | $114,221 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 2,795 | 2,943 | 1,332 | 1,472 | 432 |
| TOTAL | $2,795 | $2,943 | $1,332 | $1,472 | $432 |
| Total Assets | $218,240 | $230,633 | $119,817 | $105,293 | $114,653 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 930 | 788 | 790 | 995 | 931 |
| Accrued Expenses | 5,156 | 7,690 | 5,073 | 3,657 | 3,852 |
| TOTAL | $6,673 | $9,060 | $6,441 | $5,225 | $4,967 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 95,531 | 96,755 | 96,902 | 97,047 | 96,398 |
| TOTAL | $95,531 | $96,755 | $96,902 | $97,047 | $96,398 |
| Total Liabilities | $102,204 | $105,815 | $103,343 | $102,272 | $101,365 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,026 | 27,987 | 16,826 | 13,017 | 13,017 |
| Common Shares | 28 | 28 | 16 | 13 | 13 |
| Retained earnings | -518,831 | -507,643 | -494,380 | -482,383 | -471,132 |
| Other shareholders' equity | -4 | -79 | -215 | -186 | -53 |
| TOTAL | $116,036 | $124,818 | $16,474 | $3,021 | $13,288 |
| Total Liabilities And Equity | $218,240 | $230,633 | $119,817 | $105,293 | $114,653 |